These results suggested that inhibition of the PD-1/PD-L1 immune checkpoint can relieve the immunosuppressive function of CAR-NK cells, prolong the persistence of cytotoxicity, and enhance the toxicity of CAR-NK cell to tumor cell. This evidence concerns the gene CD274 and neoplasm.